Bioprospecting the Efficacy and Safety of Natural Products from Plants

A special issue of Plants (ISSN 2223-7747). This special issue belongs to the section "Phytochemistry".

Deadline for manuscript submissions: 30 August 2024 | Viewed by 881

Special Issue Editors


E-Mail Website
Guest Editor
Laboratory of Experimental Pathology (LAPATEX), Federal University of São João del-Rei, Midwest Campus (Dona Lindu), St. Sebastião Gonçalves Coelho, 400-Chanadour, Divinópolis 35501-296, MG, Brazil
Interests: drug delivery; antioxidants; nutraceuticals; phytotherapics; phytochemicals; cell biology; pathology experimental; natural products; programmed cell death; autophagy

E-Mail Website
Guest Editor
Laboratory of Pharmaceutical Development (LADEF), Federal University of São João del-Rei, Midwest Campus (Dona Lindu), St. Sebastião Gonçalves Coelho, 400-Chanadour, Divinópolis 35501-296, MG, Brazil
Interests: drug delivery; antioxidants; nutraceuticals; phytotherapics; multivariate statistical analysis; quality-by-design; phytochemicals; cell biology; autophagy; programmed cell death; plant anatomy
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Plants have been widely studied for their metabolic richness and ability to produce bioactive substances of health interest. These substances are from complex biochemical machinery and are evaluated for their ability to alter pathways that may be related to the cell survival of pathogens (antimicrobials and antivirals), pathways associated with the sequestration of free radicals (antioxidants), or cell toxicity (antitumors), among others. In general, phytotherapy is correlated with a low cytotoxic profile for normal cells, in addition to the fact that many extracts contain metabolites involved in cell detoxification.

Secondary metabolites derived from plants have an extensive history in traditional and modern societies. The discovery of new chemotherapeutic agents from natural products has stimulated the search for new bioactives that can modulate pathways related to the progression of various acute and chronic diseases. One of the most important plant explorations was the isolation of the alkaloids vinblastine and vincristine from Catharanthus roseus (L.) G. Don (Apocynaceae), popularly known as vinca. This plant was initially used to treat diabetes mellitus, and currently, the isolated alkaloids are widely used commercially in therapy against various types of tumors.

As a result, research into different plants, which are powerful sources of bioactive secondary metabolites, has taken up a lot of space in the search for new drugs, especially against cancer, which are as effective as existing chemotherapy drugs and less aggressive toward normal cells.

In this Special Issue, we invite scientists who are dedicated to the bioprospecting of natural products derived from plants. The topics of interest are i) the isolation, identification, and semi-synthesis of bioactive phytochemicals; ii) pre-clinical (in vitro and in vivo) and clinical evaluation of efficacy and safety for pharmacological and toxicological validation of phytocomplexes; iii) studies of unit operations and analytical standardization of plant extracts; and iv) the development of release systems for phytochemicals of medical, biomedical, and veterinary interest. Scientific contributions on subjects relevant to phytotherapy, e.g., metabolomics, experimental pathology, the effect of seasonality on bioactivities, and pharmacometrics are very welcome.

Full original and review articles will be considered for publication. Contributions must contain information on the botanical identification of the species under study, including the deposit of voucher specimens in herbaria, and the phytochemical characterization of plant extracts. Only systematic reviews prepared following the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020- https://www.bmj.com/content/372/bmj.n71) will be considered.

Prof. Dr. Rosy Iara Maciel de Azambuja Ribeiro
Prof. Dr. Renê Oliveira Do Couto
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Plants is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • in vitro techniques
  • phytochemicals
  • antioxidants
  • medicinal plant
  • toxic plants
  • drug delivery systems
  • animal disease models
  • drug screening
  • pharmacognosy
  • plant extracts

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

10 pages, 1058 KiB  
Article
Phenolic Monoterpenes Conversion of Conobea scoparioides Essential Oil by Hydrotalcite Synthesized from Blast-Furnace Slag
by Monaliza M. Rebelo, Eloisa Helena A. Andrade, José Augusto M. Corrêa and José Guilherme S. Maia
Plants 2024, 13(9), 1199; https://doi.org/10.3390/plants13091199 - 25 Apr 2024
Viewed by 185
Abstract
Conobea scoparioides (Plantaginaceae) is an herbaceous plant known as “pataqueira” that grows wild in seasonally wet areas of the Amazon region. It is used for aromatic baths and anti-protozoan remedies by the Brazilian Amazon native people. The main volatile compounds identified in the [...] Read more.
Conobea scoparioides (Plantaginaceae) is an herbaceous plant known as “pataqueira” that grows wild in seasonally wet areas of the Amazon region. It is used for aromatic baths and anti-protozoan remedies by the Brazilian Amazon native people. The main volatile compounds identified in the essential oil of “Pataqueira” were the phenolic monoterpenes thymol and thymol methyl ether and their precursors, the monoterpene hydrocarbons α-phellandrene and p-cymene. A hydrotalcite synthesized from blast-furnace slag exhibited a 3:2 (Mg/Al) molar ratio, and this layered double hydroxide (LDH) was evaluated as a catalyst in converting the main monoterpenes of the “Pataqueira” oil. This action significantly increased the thymol content, from 41% to 95%, associated with the percentual reduction in other main components, such as thymol methyl ether, α-phellandrene, and p-cymene. The LDH reaction showed a strong tendency towards producing hydroxylated derivatives, and its behavior was similar to the hypothetical plant biosynthetic pathway, which leads to the production of the monoterpenes of “Pataqueira” oil. Thymol and its derivatives are potent antiseptics applied in pharmaceutical and hygienic products as antibacterial, antifungal, and antioxidant properties, among others. The present work reports a natural source with a high thymol content in aromatic plants from the Amazon, with evident economic value. Full article
Show Figures

Figure 1

Other

Jump to: Research

9 pages, 924 KiB  
Brief Report
Antioxidant and Anti-Melanogenesis Effects of Teucrium chamaedrys L. Cell Suspension Extract and Its Main Phenylethanoid Glycoside in B16-F10 Cells
by Letizia Pruccoli, Benedetta Nicolini, Mariacaterina Lianza, Gabriella Teti, Mirella Falconi, Andrea Tarozzi and Fabiana Antognoni
Plants 2024, 13(6), 808; https://doi.org/10.3390/plants13060808 - 12 Mar 2024
Viewed by 496
Abstract
Teucrium chamaedrys L. is a typical European–Mediterranean species of the genus Teucrium. Among the phenolic compounds belonging to phenylethanoid glycosides (PGs), teucrioside (TS) is only found in this species, and it was previously demonstrated to be produced by in vitro-elicited cell cultures at [...] Read more.
Teucrium chamaedrys L. is a typical European–Mediterranean species of the genus Teucrium. Among the phenolic compounds belonging to phenylethanoid glycosides (PGs), teucrioside (TS) is only found in this species, and it was previously demonstrated to be produced by in vitro-elicited cell cultures at levels higher than those found in leaves. However, T. chamaedrys cell suspension extracts (Cell-Ex) and pure TS have not been investigated yet for any biological effects. In this study, we evaluated the antioxidant and anti-melanogenesis activity of both Cell-Ex and TS in B16-F10 mouse melanoma cells. The results showed that Cell-Ex inhibited the reactive oxygen species formation evoked in B16-F10 cells by tert-butyl hydroperoxide and 5 J/cm2 of UVA, as well as the melanin increase stimulated by α-MSH or 20 J/cm2 of UVA. In parallel, a TS concentration equivalent to that present in Cell-Ex recorded the same biological effect profile, suggesting the main contribution of TS to the antioxidant and anti-melanogenic properties of Cell-Ex. Both Cell-Ex and TS also modulated the melanogenesis pathway through their ability to inhibit the tyrosinase activity both in a cell-free system and in B16-F10 cells stimulated by α-MSH. These results support the potential cosmeceutical use of Cell-Ex for protection against photooxidative damage and hyperpigmentation. Full article
Show Figures

Figure 1

Back to TopTop